ASA inhibits cyclooxygenase-1 (COX-1) and thromboxane-dependent platelet activation, which decreases the probability of acute thrombosis related proximally to cardiac and stroke events [2-4]. This evidence concerns the gene PTGS1 and stroke disorder.